{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:29:51Z","timestamp":1763663391902},"reference-count":13,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.3892\/etm.2015.2791","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T05:12:14Z","timestamp":1444713134000},"page":"2213-2215","source":"Crossref","is-referenced-by-count":7,"title":["A rare case of juvenile localised scleroderma with intra-oral and dental involvement"],"prefix":"10.3892","volume":"10","author":[{"given":"PENG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEI","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHUTAI","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"key20180108124656_b1-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"key20180108124656_b2-etm-0-0-2791","first-page":"5","article-title":"Preliminary classification criteria for juvenile systemic sclerosis","author":"Zulian","year":"2005","journal-title":"Proceedings of the II Workshop on nomenclature and diagnostic criteria for Juvenile Scleroderma Syndromes"},{"key":"key20180108124656_b3-etm-0-0-2791","first-page":"347","author":"Newman","year":"2012","journal-title":"Carranzas Clinical Periodontology"},{"key":"key20180108124656_b4-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.det.2012.12.002","article-title":"Pediatric morphea","volume":"31","author":"Browning","year":"2013","journal-title":"Dermatol Clin"},{"key":"key20180108124656_b5-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"key20180108124656_b6-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0049-0172(94)90028-0","article-title":"Localized scleroderma in childhood: A report of 30 cases","volume":"23","author":"Uziel","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"key20180108124656_b7-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","article-title":"Localized scleroderma","volume":"18","author":"Laxer","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"key20180108124656_b8-etm-0-0-2791","first-page":"14","article-title":"Generalized morphea successfully treated with tacrolimus 0.1% ointment","volume":"12","author":"Cantisani","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"key20180108124656_b9-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study","volume":"10","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"key20180108124656_b10-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2012.03.036","article-title":"A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea)","volume":"67","author":"Zulian","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key20180108124656_b11-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1111\/j.1525-1470.2012.01882.x","article-title":"Successful combination treatment of a patient with progressive juvenile localized scleroderma (morphea) using imatinib, corticosteroids, and methotrexate","volume":"30","author":"Inamo","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"key20180108124656_b12-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clindermatol.2013.01.011","article-title":"Treatment regimens, protocols, dosage and indications for UVA1 phototherapy: Facts and controversies","volume":"31","author":"Gambichler","year":"2013","journal-title":"Clin Dermatol"},{"key":"key20180108124656_b13-etm-0-0-2791","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2013.09.007","article-title":"Total glucosides of paeony inhibit the proliferation of fibroblast-like synoviocytes through the regulation of G proteins in rats with collagen-induced arthritis","volume":"18","author":"Jia","year":"2014","journal-title":"Int Immunopharmacol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2791\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:01:29Z","timestamp":1515448889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,10,12]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.3892\/etm.2015.2791"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2791","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}